Literature DB >> 17255231

Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea.

Moses J Bockarie1, Livingstone Tavul, Irvin Ibam, Will Kastens, Fred Hazlett, Daniel J Tisch, Michael P Alpers, James W Kazura.   

Abstract

The efficacy of diethylcarbamazine alone was compared with diethylcarbamazine plus albendazole in residents of an island in Papua New Guinea endemic for Wuchereria bancrofti. There was no statistically significant difference between the two drug regimens in decreasing the microfilaria positive rate at 12 and 24 months after a single-dose treatment with either regimen, e.g., 50.0% clearance of microfilaria at 24 months for diethylcarbamazine alone versus 65.7% clearance of microfilaria for diethylcarbamazine plus albendazole (P > 0.05). In contrast, diethylcarbamazine plus albendazole resulted in a significant decrease in Og4C3 antigen prevalence (17%; P = 0.003) at 24 months whereas diethylcarbamazine did not (10%; P = 0.564). These data showed no statistically significant difference in the efficacy of the two drug regimens in lowering the microfilaria reservoir, but they support the use of diethylcarbamazine combined with albendazole in mass treatment programs on the basis of greater activity against adult worms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255231

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.

Authors:  Daniel J Tisch; Moses J Bockarie; Zachary Dimber; Benson Kiniboro; Nandao Tarongka; Fred E Hazlett; Will Kastens; Michael P Alpers; James W Kazura
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

2.  Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.

Authors:  Jennifer S F da Silva; Cynthia Braga; Felipe M Duarte; Paula Oliveira; Carlos Feitosa Luna; Márcia Marcondes; Josué Araújo; Maria Rosangela Grilis; Paula Fernanda A de Souza Melo; Eduardo Brandão; Abraham Rocha
Journal:  Pathog Glob Health       Date:  2018-08-15       Impact factor: 2.894

3.  Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.

Authors:  Nilima A Kshirsagar; N J Gogtay; B S Garg; P R Deshmukh; D D Rajgor; V S Kadam; P A Thakur; A Gupta; N S Ingole; J K Lazdins-Helds
Journal:  Parasitol Res       Date:  2017-08-07       Impact factor: 2.289

4.  A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia.

Authors:  Laura R Serbus; Frederic Landmann; Walter M Bray; Pamela M White; Jordan Ruybal; R Scott Lokey; Alain Debec; William Sullivan
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

5.  Current evidence on the use of antifilarial agents in the management of bancroftian filariasis.

Authors:  Sumadhya Deepika Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  J Trop Med       Date:  2010-12-30

6.  Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.

Authors:  Cara L Macfarlane; Shyam S Budhathoki; Samuel Johnson; Marty Richardson; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2019-01-08

7.  A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.

Authors:  Christopher L King; James Suamani; Nelly Sanuku; Yao-Chieh Cheng; Samson Satofan; Brooke Mancuso; Charles W Goss; Leanne J Robinson; Peter M Siba; Gary J Weil; James W Kazura
Journal:  N Engl J Med       Date:  2018-11-08       Impact factor: 91.245

Review 8.  Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.

Authors:  Patricia M Graves; Leo Makita; Melinda Susapu; Molly A Brady; Wayne Melrose; Corinne Capuano; Zaixing Zhang; Luo Dapeng; Masayo Ozaki; David Reeve; Kazuyo Ichimori; Walter M Kazadi; Frederick Michna; Moses J Bockarie; Louise A Kelly-Hope
Journal:  Parasit Vectors       Date:  2013-01-11       Impact factor: 3.876

9.  The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.

Authors:  Gary J Weil; Will Kastens; Melinda Susapu; Sandra J Laney; Steven A Williams; Christopher L King; James W Kazura; Moses J Bockarie
Journal:  PLoS Negl Trop Dis       Date:  2008-12-09

10.  Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection.

Authors:  Michael A Irvine; Sammy M Njenga; Shamini Gunawardena; Claire Njeri Wamae; Jorge Cano; Simon J Brooker; T Deirdre Hollingsworth
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-02       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.